SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-03-002477
Filing Date
2003-02-28
Accepted
2003-02-28 13:28:10
Documents
10
Period of Report
2002-12-28

Document Format Files

Seq Description Document Type Size
1 NABI BIOPHARMACEUTICALS FORM 10-K 12/28/02 g80877e10vk.htm 10-K 789823
3 AGREEMENT OF SUBSTITUTION & AMENDT. RIGHTS AGRMT. g80877exv4w4.txt EX-4.4 8420
4 EMPLOYMENT AGREEMENT - GREENLEAF g80877exv10w31.txt EX-10.31 17471
5 INDEMNIFICATION AGREEMENT - SMITH g80877exv10w32.txt EX-10.32 19636
6 INDEMNIFICATION AGREEMENT - MCLAIN g80877exv10w33.txt EX-10.33 19636
7 INDEMNIFICATION AGREEMENT - GREENLEAF g80877exv10w34.txt EX-10.34 19685
8 AMENDED AGREEMENT LETTER g80877exv10w35.txt EX-10.35 25855
9 SUBSIDIARIES g80877exv21.txt EX-21 673
10 CONSENT OF ERNST & YOUNG LLP g80877exv23w1.txt EX-23.1 1009
11 CERTIFICATION OF CEO & CFO g80877exv99w1.txt EX-99.1 1738
  Complete submission text file 0000950144-03-002477.txt   906958
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-K | Act: 34 | File No.: 000-04829 | Film No.: 03585709
SIC: 2836 Biological Products, (No Diagnostic Substances)